AP2547A - Quinoline derivatives as antibacterial agents - Google Patents

Quinoline derivatives as antibacterial agents

Info

Publication number
AP2547A
AP2547A AP2008004298A AP2008004298A AP2547A AP 2547 A AP2547 A AP 2547A AP 2008004298 A AP2008004298 A AP 2008004298A AP 2008004298 A AP2008004298 A AP 2008004298A AP 2547 A AP2547 A AP 2547A
Authority
AP
ARIPO
Prior art keywords
antibacterial agents
quinoline derivatives
quinoline
derivatives
antibacterial
Prior art date
Application number
AP2008004298A
Other languages
English (en)
Inventor
Koenraad Jozef Lodewijk Marcel Andries
Anil Koul
David Francis Alain Laneois
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35447198&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP2547(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of AP2547A publication Critical patent/AP2547A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)
AP2008004298A 2005-06-28 2006-06-26 Quinoline derivatives as antibacterial agents AP2547A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05105755 2005-06-28

Publications (1)

Publication Number Publication Date
AP2547A true AP2547A (en) 2012-12-26

Family

ID=35447198

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2008004298A AP2547A (en) 2005-06-28 2006-06-26 Quinoline derivatives as antibacterial agents

Country Status (32)

Country Link
US (1) US20130030016A1 (ar)
EP (1) EP1898909B1 (ar)
JP (1) JP5193857B2 (ar)
KR (1) KR101329587B1 (ar)
CN (1) CN101252927B (ar)
AP (1) AP2547A (ar)
AR (1) AR054804A1 (ar)
AU (1) AU2006263882B2 (ar)
BR (1) BRPI0613999B8 (ar)
CA (1) CA2612614C (ar)
CY (1) CY1119402T1 (ar)
DK (1) DK1898909T3 (ar)
EA (1) EA014431B1 (ar)
ES (1) ES2610472T3 (ar)
HK (1) HK1120732A1 (ar)
HR (1) HRP20170044T1 (ar)
HU (1) HUE030264T2 (ar)
IL (1) IL188395A (ar)
JO (1) JO3322B1 (ar)
LT (1) LT1898909T (ar)
MX (1) MX2008000079A (ar)
MY (1) MY173664A (ar)
NO (1) NO341285B1 (ar)
NZ (1) NZ564340A (ar)
PL (1) PL1898909T3 (ar)
PT (1) PT1898909T (ar)
RS (1) RS55601B1 (ar)
SG (1) SG166798A1 (ar)
TW (1) TWI413520B (ar)
UA (1) UA88701C2 (ar)
WO (1) WO2007000434A1 (ar)
ZA (1) ZA200711148B (ar)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2752B1 (ar) 2005-06-28 2014-03-15 شركة جانسين فارماسوتيكا ان. في مشتقات كوينولين بصفة عوامل مضادة للبكتيريا
JO2683B1 (ar) * 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان. في مشتقات الكوينولين المضادة للجراثيم
JO2970B1 (ar) 2006-12-06 2016-03-15 جانسين فارماسوتيكا ان. في مشتقات الكوينولين المضادة للجراثيم
JP5397881B2 (ja) * 2008-09-04 2014-01-22 昇一 城武 グラム陽性細菌用抗菌剤及び抗菌活性増強剤
CN104254527B (zh) 2012-04-27 2017-05-31 詹森药业有限公司 抗菌的喹啉衍生物
AU2013254670B2 (en) 2012-04-27 2017-03-30 Janssen Pharmaceutica Nv Antibacterial quinoline derivatives
AU2018348796A1 (en) * 2017-10-13 2020-05-07 Griffith University Zinc ionophores and uses thereof
CN110606825A (zh) * 2019-10-30 2019-12-24 成都海杰亚医药科技有限公司 一种制备吡啶-2-硫醇的方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004011436A1 (en) * 2002-07-25 2004-02-05 Janssen Pharmaceutica N.V. Quinoline derivatives and their use as mycobacterial inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103905A (en) * 1997-06-19 2000-08-15 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
DK1753427T3 (da) * 2004-05-28 2008-07-21 Janssen Pharmaceutica Nv Anvendelse af substituerede quinolinderivater til behandling af lægemiddelresistente mykobakteriesygdomme
EE05394B1 (et) * 2004-12-24 2011-04-15 Janssen Pharmaceutica N.V. Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis
CA2528849C (en) * 2005-06-08 2014-01-14 Janssen Pharmaceutica N.V. Quinoline derivatives as antibacterial agents

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004011436A1 (en) * 2002-07-25 2004-02-05 Janssen Pharmaceutica N.V. Quinoline derivatives and their use as mycobacterial inhibitors

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ANDRIES, KOEN ET AL.: SCIENCE, vol. 307, 14 January 2005 (2005-01-14), pages 223-227, XP002358962, cited in the application, page 223-page 224 *
DESAI P.K. ET AL.: "QUINOLINE DERIVATIVES AS ANTITUBERCULAR/ANTIBACTERIAL AGENTS", INDIAN JOURNAL OF CHEMISTRY, JODHPUR, IN, vol. 35B, no. 8, August 1996 (1996-08), pages 871-873, XP000944820, the whole document *
HELWIG, BURGHARD: "Moderne Arzneimittel", 1980, WISSENSCHAFTLICHE VERLAGSGESELLSCHAFT, STUTTGART, XP002359316, page 395 *

Also Published As

Publication number Publication date
CA2612614A1 (en) 2007-01-04
CY1119402T1 (el) 2018-03-07
AR054804A1 (es) 2007-07-18
IL188395A (en) 2012-05-31
KR20080028459A (ko) 2008-03-31
DK1898909T3 (en) 2017-02-06
TWI413520B (zh) 2013-11-01
PT1898909T (pt) 2016-12-07
UA88701C2 (ru) 2009-11-10
BRPI0613999A2 (pt) 2011-03-01
BRPI0613999B8 (pt) 2021-05-25
MX2008000079A (es) 2008-03-19
JO3322B1 (ar) 2019-03-13
PL1898909T3 (pl) 2017-03-31
LT1898909T (lt) 2017-02-10
TW200800183A (en) 2008-01-01
EP1898909B1 (en) 2016-10-19
BRPI0613999B1 (pt) 2020-04-22
EA014431B1 (ru) 2010-12-30
WO2007000434A1 (en) 2007-01-04
AU2006263882B2 (en) 2012-12-13
EP1898909A1 (en) 2008-03-19
ES2610472T3 (es) 2017-04-27
SG166798A1 (en) 2010-12-29
HRP20170044T1 (hr) 2017-03-10
CN101252927B (zh) 2014-01-01
AU2006263882A1 (en) 2007-01-04
NZ564340A (en) 2011-02-25
HK1120732A1 (en) 2009-04-09
IL188395A0 (en) 2008-08-07
JP2008546824A (ja) 2008-12-25
CN101252927A (zh) 2008-08-27
CA2612614C (en) 2017-07-25
JP5193857B2 (ja) 2013-05-08
NO20080499L (no) 2008-02-29
MY173664A (en) 2020-02-14
ZA200711148B (en) 2013-03-27
RS55601B1 (sr) 2017-06-30
US20130030016A1 (en) 2013-01-31
KR101329587B1 (ko) 2013-11-15
EA200800151A1 (ru) 2008-06-30
HUE030264T2 (en) 2017-04-28
NO341285B1 (no) 2017-10-02

Similar Documents

Publication Publication Date Title
IL189141A0 (en) Quinoline derivatives as antibacterial agents
AP2654A (en) Quinoline derivatives as antibacterial agents
IL187904A0 (en) Quinoline derivatives as antibacterial agents
HK1120732A1 (en) Quinoline derivatives as antibacterial agents
HK1124232A1 (en) Quinoline derivatives as antibacterial agents
HK1122730A1 (en) Quinoline derivatives as antibacterial agents
HK1120734A1 (en) Quinoline derivatives as antibacterial agents
ZA200710698B (en) Quinoline derivatives as antibacterial agents